Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TOP1 | P11387 | 4/20 | 0.60 |
| ▸ | STAT3 | P40763 | 1/20 | 0.59 |
| ▸ | STAT1 | P42224 | 1/20 | 0.59 |
| ▸ | CYCS | P99999 | 3/20 | 0.58 |
| ▸ | TERT | O14746 | 4/20 | 0.57 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30136 | 0.96 | TOP1 (0.64) | TOP1STAT3STAT1CYCSTERT | |
| SCHEMBL29405434 | 0.96 | TOP1 (0.64) | TOP1STAT3STAT1CYCSTERT | |
| SCHEMBL7987113 | 0.94 | TOP1 (0.62) | TOP1STAT3STAT1CYCSTERT | |
| SCHEMBL9640434 | 0.94 | TOP1 (0.62) | TOP1STAT3STAT1CYCSTERT | |
| SCHEMBL483081 | 0.94 | TOP1 (0.62) | TOP1STAT3STAT1CYCSTERT | |
| SCHEMBL8014529 | 0.94 | TOP1 (0.62) | TOP1STAT3STAT1CYCSTERT | |
| SCHEMBL15085674 | 0.94 | TOP1 (0.62) | TOP1STAT3STAT1CYCSTERT | |
| SCHEMBL1313700 | 0.94 | TOP1 (0.62) | TOP1STAT3STAT1CYCSTERT | |
| SCHEMBL8014524 | 0.94 | TOP1 (0.62) | TOP1STAT3STAT1CYCSTERT | |
| SCHEMBL991489 | 0.94 | TOP1 (0.62) | TOP1STAT3STAT1CYCSTERT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260048152-A1 | GEMCITABINE INORGANIC-ORGANIC HYBRID NANOPARTICLES | KARLSRUHER INSTITUT FUER TECH KOERPERSCHAFT DES OEFFENTLICHEN RECHTS (DE) | 2026-02-19 | — | — | US | claimed |
| US-12145951-B2 | Inorganic-organic hybrid compounds including organic platinum-containing anions, for use in medicine | KARLSRUHER INSTITUT FUR TECHNOLOGIE (DE) | 2024-11-19 | — | — | US | claimed |
| US-20220267361-A1 | CORROLE-BASED FRAMEWORKS AND METHODS OF USE THEREOF | UNIVERSITY OF SOUTH FLORIDA | 2022-08-25 | — | — | US | claimed |
| US-20210292353-A1 | INORGANIC-ORGANIC HYBRID COMPOUNDS INCLUDING ORGANIC PLATINUM-CONTAINING ANIONS, FOR USE IN MEDICINE | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2021-09-23 | — | — | US | claimed |
| EP-3829565-A1 | INORGANIC-ORGANIC HYBRID COMPOUNDS INCLUDING ORGANIC PLATINUM-CONTAINING ANIONS, FOR USE IN MEDICINE | Karlsruher Institut für Technologie (DE) | 2021-06-09 | — | — | EP | claimed |
| WO-2021035010-A1 | CORROLE-BASED FRAMEWORKS AND METHODS OF USE THEREOF | MA SHENGQIAN (US) | 2021-02-25 | — | — | WO | claimed |
| WO-2020025488-A1 | INORGANIC-ORGANIC HYBRID COMPOUNDS INCLUDING ORGANIC PLATINUM-CONTAINING ANIONS, FOR USE IN MEDICINE | Karlsruher Institut für Technologie (DE) | 2020-02-06 | — | — | WO | claimed |
| US-20170112948-A1 | Inorganic-organic hybrid compound | Karlsruher Institut für Technologie (DE) | 2017-04-27 | — | — | US | claimed |
| US-8480928-B2 | Inorganic-organic composite luminophore | KARLSRUHER INSTITUT FUR TECHNOLOGIE (KIT) (DE) | 2013-07-09 | — | — | US | claimed |
| US-20110198538-A1 | INORGANIC-ORGANIC COMPOSITE LUMINOPHORE | Karlsruher Institut for Technologie (KIT) (DE) | 2011-08-18 | — | — | US | claimed |
| EP-2179006-A1 | INORGANIC-ORGANIC COMPOSITE FLUORESCENT SUBSTANCE | Karlsruher Institut für Technologie (DE) | 2010-04-28 | — | — | EP | claimed |
| WO-2009100800-A1 | INORGANIC-ORGANIC COMPOSITE FLUORESCENT SUBSTANCE | UNIVERSITÄT KARLSRUHE (TH) (DE) | 2009-08-20 | — | — | WO | claimed |
| US-20260048152-A1 | GEMCITABINE INORGANIC-ORGANIC HYBRID NANOPARTICLES | KARLSRUHER INSTITUT FUER TECH KOERPERSCHAFT DES OEFFENTLICHEN RECHTS (DE) | 2026-02-19 | — | — | US | disclosed |
| US-12145951-B2 | Inorganic-organic hybrid compounds including organic platinum-containing anions, for use in medicine | KARLSRUHER INSTITUT FUR TECHNOLOGIE (DE) | 2024-11-19 | — | — | US | disclosed |
| US-11629160-B2 | Corrole-based frameworks and methods of use thereof | UNIVERSITY OF SOUTH FLORIDA (US) | 2023-04-18 | — | — | US | disclosed |
| US-20220267361-A1 | CORROLE-BASED FRAMEWORKS AND METHODS OF USE THEREOF | UNIVERSITY OF SOUTH FLORIDA | 2022-08-25 | — | — | US | disclosed |
| WO-2015043533-A1 | PHOTOVOLTAIC CONVERSION ELEMENT AND PHOTOVOLTAIC CELL | THE UNIVERSITY OF HONG KONG (CN) | 2015-04-02 | — | — | WO | disclosed |
| US-20150090337-A1 | PHOTOVOLTAIC CONVERSION ELEMENT AND PHOTOVOLTAIC CELL | THE UNIVERSITY OF HONG KONG (HK) | 2015-04-02 | — | — | US | disclosed |
| EP-2179006-A1 | INORGANIC-ORGANIC COMPOSITE FLUORESCENT SUBSTANCE | Karlsruher Institut für Technologie (DE) | 2010-04-28 | — | — | EP | disclosed |
| WO-2009100800-A1 | INORGANIC-ORGANIC COMPOSITE FLUORESCENT SUBSTANCE | UNIVERSITÄT KARLSRUHE (TH) (DE) | 2009-08-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260048152-A1 | GEMCITABINE INORGANIC-ORGANIC HYBRID NANOPARTICLES | GOT1, RNMT, GNAO1 | TOP1 261/4885STAT3 1715/4885STAT1 994/4885 |
| US-11629160-B2 | Corrole-based frameworks and methods of use thereof | CA13, CA12, ERCC4 | TOP1 1379/4885STAT3 2245/4885STAT1 2505/4885 |
| US-20170112948-A1 | Inorganic-organic hybrid compound | SLCO4C1, SLCO2A1, SLCO1A2 | TOP1 3915/4885STAT3 2646/4885STAT1 4147/4885 |
| US-20220267361-A1 | CORROLE-BASED FRAMEWORKS AND METHODS OF USE THEREOF | CA13, CA12, ERCC4 | TOP1 1379/4885STAT3 2245/4885STAT1 2505/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.